HSIE Results Daily: Sun Pharmaceutical Industries, Bajaj Auto, Jindal Steel...

152 Views03 Feb 2026 09:35

Broker

Sun Pharmaceutical Industries: EBITDA (ex-milestone of USD 55 mn) grew 13% YoY on 13% sales growth (US: -4% QoQ, global specialty: +13% QoQ, India: +16% YoY) and higher gross margin

What is covered in the Full Insight:

Introduction
Financial Performance Overview
Specialty Business Growth
Innovative Pipeline and New Launches
Strategic Initiatives and M&As

HDFC Securities

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 25-minute read)

Discussions

(Paid Plans Only)

Insight Stream

HSIE Results Daily: Sun Pharmaceutical Industries, Bajaj Auto, Jindal Steel...
03 Feb 2026